Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
MedifastMED | Open-market sale10b5-1 plan | 09/28–09/29 | 09/30 | 19,089 sh2 trades | $11.85avg. | $226,288.77 | −12.8% | |
MedifastMED | Open-market buy | 05/08–05/11 | 05/12 | 5,000 sh2 trades | $12.59avg. | $62,950 | +19.6% | |
Daniel R. ChardChairman & CEO | MedifastMED | Open-market buy | 03/20 | 03/27 | 17,678 sh | $10.11 | $178,724.58 | No record |
Daniel R. ChardChairman & CEO | MedifastMED | Open-market buy | 25/06/13 | 25/06/17 | 381 sh | $13.13 | $5,002.53 | +0.3% |
MedifastMED | Open-market sale | 24/03/08 | 24/03/12 | 4,053 sh2 trades | $39.44avg. | $159,866.38 | −34.2% | |
MedifastMED | Open-market buy | 23/11/03–23/11/07 | 23/11/09 | 155.09 sh2 trades | $69.93avg. | $10,844.74 | No record | |
Scott SchlackmanDirector | MedifastMED | Open-market buy | 23/11/07 | 23/11/09 | 52.65 sh | $68.89 | $3,627.06 | +0.5% |
Michael A. HoerDirector | MedifastMED | Open-market buy | 23/11/07 | 23/11/09 | 49.76 sh | $68.89 | $3,427.97 | +0.6% |
Andrea B. ThomasDirector | MedifastMED | Open-market buy | 23/11/07 | 23/11/09 | 50.39 sh | $68.89 | $3,471.37 | +0.8% |
MedifastMED | Open-market sale | 23/10/06 | 23/10/30 | 5,613 sh | $73.87 | $414,632.31 | −72.3% | |
MedifastMED | Open-market sale | 23/08/14–23/08/15 | 23/08/16 | 38,316 sh3 trades | $91.14avg. | $3,492,040.78 | −100.0% | |
MedifastMED | Open-market buy | 23/08/04–23/08/08 | 23/08/10 | 733.03 sh3 trades | $99.39avg. | $72,856.66 | No record | |
Scott SchlackmanDirector | MedifastMED | Open-market buy | 23/08/08 | 23/08/10 | 39.82 sh | $89.42 | $3,560.7 | +0.4% |
Michael A. HoerDirector | MedifastMED | Open-market buy | 23/08/08 | 23/08/10 | 37.64 sh | $89.42 | $3,365.77 | +0.5% |
Andrea B. ThomasDirector | MedifastMED | Open-market buy | 23/08/08 | 23/08/10 | 38.12 sh | $89.42 | $3,408.69 | +0.6% |
MedifastMED | Open-market buy | 23/05/05–23/05/09 | 23/05/11 | 769.02 sh3 trades | $89.70avg. | $68,978.19 | No record | |
Constance J. HallquistDirector | MedifastMED | Open-market buy | 23/05/09 | 23/05/11 | 13.34 sh | $87.50 | $1,167.25 | +0.2% |
Scott SchlackmanDirector | MedifastMED | Open-market buy | 23/05/09 | 23/05/11 | 13.15 sh | $87.50 | $1,150.63 | +0.2% |
Michael A. HoerDirector | MedifastMED | Open-market buy | 23/05/09 | 23/05/11 | 12.77 sh | $87.50 | $1,117.38 | +0.2% |
Andrea B. ThomasDirector | MedifastMED | Open-market buy | 23/05/09 | 23/05/11 | 12.95 sh | $87.50 | $1,133.13 | +0.4% |